Hybrid coronary revascularization for the treatment of coronary artery disease

VernacularTitle:复合技术在冠状动脉血运重建中的应用
Author: Dongmei SHI ¹ ; Hongya HAN
Author Information

1. 首都医科大学附属北京安贞医院心内科12病房　北京市心肺血管疾病研究所　冠心病精准治疗北京市重点实验室　首都医科大学冠心病临床诊疗与研究中心　100029
Keywords: Coronary artery disease; Myocardial revascularization; Coronary artery bypass; Angioplasty, balloon, coronary
From: Chinese Journal of Surgery 2020;58(5):E005-E005
CountryChina
Language:Chinese
Abstract: Hybrid coronary revascularization (HCR) combines the respective strengths of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) for selected patients with multivessel coronary artery disease. HCR includes the minimally invasive direct coronary artery bypass of a left internal thoracic artery graft to the left anterior descending artery (LAD) with stenting of non-LAD lesions with PCI, in onestop or staged hybrid procedures.HCR can prove superiority to conventional CABG in clinical complications. Many available data suggests that HCR is feasible and safe in skilled hands. Further large-scale randomized controlled trials are in great need. HCR may become another more commonly used interventional strategy for certain patients with multivessel coronary artery disease.